Agenus, Inc. (AGEN)
3.96
-0.12
(-2.94%)
USD |
NASDAQ |
Dec 12, 10:45
Agenus Research and Development Expense (TTM): 105.60M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Inovio Pharmaceuticals, Inc. | 55.38M |
| Armata Pharmaceuticals, Inc. | 26.10M |
| Bionano Genomics, Inc. | 11.62M |
| Twist Bioscience Corp. | 80.28M |
| AIM ImmunoTech, Inc. | 3.826M |